INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$582K

$582,315

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
KALV S KalVista Pharmaceuticals, Inc. Palleiko Benjamin L • CEO Sell to Cover 2026-03-09 $107,633 View Form 4 →
KALV	KalVista Pharmaceuticals, Inc.	Palleiko Benjamin L CEO Sell to Cover	2026-03-09	$107,633	S	Form 4
KALV S KalVista Pharmaceuticals, Inc. Palleiko Benjamin L • CEO Sell to Cover 2026-02-23 $156,197 View Form 4 →
KALV	KalVista Pharmaceuticals, Inc.	Palleiko Benjamin L CEO Sell to Cover	2026-02-23	$156,197	S	Form 4
KALV S KalVista Pharmaceuticals, Inc. Palleiko Benjamin L • CEO Sell to Cover 2026-02-18 $15,570 View Form 4 →
KALV	KalVista Pharmaceuticals, Inc.	Palleiko Benjamin L CEO Sell to Cover	2026-02-18	$15,570	S	Form 4
KALV S KalVista Pharmaceuticals, Inc. Palleiko Benjamin L • CEO Sell to Cover 2026-02-12 $52,658 View Form 4 →
KALV	KalVista Pharmaceuticals, Inc.	Palleiko Benjamin L CEO Sell to Cover	2026-02-12	$52,658	S	Form 4
KALV S KalVista Pharmaceuticals, Inc. Palleiko Benjamin L • CEO Sell to Cover 2025-11-24 $147,154 View Form 4 →
KALV	KalVista Pharmaceuticals, Inc.	Palleiko Benjamin L CEO Sell to Cover	2025-11-24	$147,154	S	Form 4
KALV S KalVista Pharmaceuticals, Inc. Palleiko Benjamin L • CEO Sell to Cover 2025-11-18 $64,665 View Form 4 →
KALV	KalVista Pharmaceuticals, Inc.	Palleiko Benjamin L CEO Sell to Cover	2025-11-18	$64,665	S	Form 4
KALV S KalVista Pharmaceuticals, Inc. Palleiko Benjamin L • CEO Sell to Cover 2025-11-12 $38,438 View Form 4 →
KALV	KalVista Pharmaceuticals, Inc.	Palleiko Benjamin L CEO Sell to Cover	2025-11-12	$38,438	S	Form 4